The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Self-citationThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Self-citationStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628
The IL-4 receptor: signaling mechanisms and biologic functions
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545
Lampropoulou, V., Sergushichev, A., Bambouskova, M., Nair, S., Vincent, E. E., Loginicheva, E., Cervantes-Barragan, L., Ma, X., Huang, S. C.-C., Griss, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.004 · Cited by 1,541
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis
Wu, D., Molofsky, A. B., Liang, H.-E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A., & Locksley, R. M. (2011) · Science · doi:10.1126/science.1201475 · Cited by 1,376
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369
Pathogenetic insights from the treatment of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31472-1 · Cited by 1,345
Self-citationDupilumab in Persistent Asthma with Elevated Eosinophil Levels
Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., Wang, L., Kirkesseli, S., Rocklin, R., Bock, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304048 · Cited by 1,320
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
Recombinant human interleukin 5 is a selective activator of human eosinophil function.
Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I. G., & Vadas, M. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.1.219 · Cited by 951
Awasthi, A., Carrier, Y., Peron, J. P. S., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007) · Nature Immunology · doi:10.1038/ni1541 · Cited by 804
Collins, P. D., Marleau, S., Griffiths-Johnson, D. A., Jose, P. J., & Williams, T. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1169 · Cited by 658
TH2, allergy and group 2 innate lymphoid cells
Licona-Limón, P., Kim, L. K., Palm, N. W., & Flavell, R. A. (2013) · Nature Immunology · doi:10.1038/ni.2617 · Cited by 646
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1517 · Cited by 529
Regulation of the host immune system by helminth parasites
Maizels, R. M., & McSorley, H. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.007 · Cited by 529
Raza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C.-Y., Akbar, A. N., Lord, J. M., Gordon, C., Buckley, C. D., & Salmon, M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1733 · Cited by 515
Elyaman, W., Bradshaw, E. M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E., Oukka, M., van Snick, J., Renauld, J.-C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812530106 · Cited by 498
The Immunobiology of Interleukin-27
Yoshida, H., & Hunter, C. A. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112134 · Cited by 467
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Xu, D., Jiang, H.-R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N. J., McInnes, I. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801898105 · Cited by 464
Haringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J. M., Kraan, M. C., Baeten, D., McInnes, I. B., Bresnihan, B., & Tak, P. P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029751 · Cited by 457
Human regulatory B cells in health and disease: therapeutic potential
Mauri, C., & Menon, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci85113 · Cited by 418
Interleukin 33 is a guardian of barriers and a local alarmin
Martin, N. T., & Martin, M. U. (2016) · Nature Immunology · doi:10.1038/ni.3370 · Cited by 408
How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
Schett, G., Elewaut, D., McInnes, I. B., Dayer, J.-M., & Neurath, M. F. (2013) · Nature Medicine · doi:10.1038/nm.3260 · Cited by 406
Self-citationInterleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406
Goswami, R., & Kaplan, M. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003049 · Cited by 399
Joosten, L. A. B., Lubberts, E., Durez, P., Helsen, M. M. A., Jacobs, M. J. M., Goldman, M., & van den Berg, W. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400209 · Cited by 397
IL-9 as a mediator of Th17-driven inflammatory disease
Nowak, E. C., Weaver, C. T., Turner, H., Begum-Haque, S., Becher, B., Schreiner, B., Coyle, A. J., Kasper, L. H., & Noelle, R. J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090246 · Cited by 393
Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
Hueber, A. J., Asquith, D. L., Miller, A. M., Reilly, J., Kerr, S., Leipe, J., Melendez, A. J., & McInnes, I. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903566 · Cited by 358
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis
Palmer, G., Talabot‐Ayer, D., Lamacchia, C., Toy, D., Seemayer, C. A., Viatte, S., Finckh, A., Smith, D. E., & Gabay, C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24305 · Cited by 313
IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation
Stolarski, B., Kurowska-Stolarska, M., Kewin, P., Xu, D., & Liew, F. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000730 · Cited by 291
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells
Rauber, S., Luber, M., Weber, S., Maul, L., Soare, A., Wohlfahrt, T., Lin, N.-Y., Dietel, K., Bozec, A., Herrmann, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4373 · Cited by 282
Self-citationMeng, X., Grötsch, B., Luo, Y., Knaup, K. X., Wiesener, M. S., Chen, X.-X., Jantsch, J., Fillatreau, S., Schett, G., & Bozec, A. (2018) · Nature Communications · doi:10.1038/s41467-017-02683-x · Cited by 274
Self-citationMattes, J., Yang, M., Mahalingam, S., Kuehr, J., Webb, D. C., Simson, L., Hogan, S. P., Koskinen, A., McKenzie, A. N. J., Dent, L. A., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020009 · Cited by 264
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
Verri, W. A., Souto, F. O., Vieira, S. M., Almeida, S. C. L., Fukada, S. Y., Xu, D., Alves-Filho, J. C., Cunha, T. M., Guerrero, A. T. G., Mattos-Guimaraes, R. B., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122655 · Cited by 263
Hirahara, K., Ghoreschi, K., Yang, X.-P., Takahashi, H., Laurence, A., Vahedi, G., Sciumè, G., Hall, A. O., Dupont, C. D., Francisco, L. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.024 · Cited by 254
Elevated interleukin-10 levels in patients with rheumatoid arthritis: ELEVATED IL-10 RA PATIENTS
Cush, J. J., Splawski, J. B., Thomas, R., Mcfarlin, J. E., Schulze-Koops, H., Davis, L. S., Fujita, K., & Lipsky, P. E. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380115 · Cited by 249
Neutrophils in rheumatoid arthritis: More than simple final effectors
Cascão, R., Rosário, H. S., Souto-Carneiro, M. M., & Fonseca, J. E. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.12.013 · Cited by 245
Regulation of IL-9 expression by IL-25 signaling
Angkasekwinai, P., Chang, S. H., Thapa, M., Watarai, H., & Dong, C. (2010) · Nature Immunology · doi:10.1038/ni.1846 · Cited by 228
McInnes, I. B., Leung, B. P., Harnett, M., Gracie, J. A., Liew, F. Y., & Harnett, W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.2127 · Cited by 212
Haschka, J., Englbrecht, M., Hueber, A. J., Manger, B., Kleyer, A., Reiser, M., Finzel, S., Tony, H.-P., Kleinert, S., Feuchtenberger, M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206439 · Cited by 201
Self-citationIL-27-induced modulation of autoimmunity and its therapeutic potential
Meka, R. R., Venkatesha, S. H., Dudics, S., Acharya, B., & Moudgil, K. D. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.08.001 · Cited by 195
Joosten, L. A., Lubberts, E., Helsen, M. M., Saxne, T., Coenen-de Roo, C. J., Heinegård, D., & van den Berg, W. B. (1999) · Arthritis Research & Therapy · doi:10.1186/ar14 · Cited by 187
IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow
Stier, M. T., Zhang, J., Goleniewska, K., Cephus, J. Y., Rusznak, M., Wu, L., Van Kaer, L., Zhou, B., Newcomb, D. C., & Peebles, R. S. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20170449 · Cited by 187
Li, Y., Zhang, P., Wang, C., Han, C., Meng, J., Liu, X., Xu, S., Li, N., Wang, Q., Shi, X., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454538 · Cited by 177
MATSUYAMA, Y., OKAZAKI, H., TAMEMOTO, H., KIMURA, H., KAMATA, Y., NAGATANI, K., NAGASHIMA, T., HAYAKAWA, M., IWAMOTO, M., YOSHIO, T., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090492 · Cited by 169
Strategies targeting the IL-4/IL-13 axes in disease
May, R. D., & Fung, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.018 · Cited by 166
Timmer, T. C. G., Baltus, B., Vondenhoff, M., Huizinga, T. W. J., Tak, P. P., Verweij, C. L., Mebius, R. E., & van der Pouw Kraan, T. C. T. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22748 · Cited by 165
Park, M.-J., Lee, S., Kim, E., Lee, E., Baek, J.-A., Park, S., Kwok, S., & Cho, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21856-2 · Cited by 165
Suppression of collagen-induced arthritis by continuous administration of IL-4
Horsfall, A. C., Butler, D. M., Marinova, L., Warden, P. J., Williams, R. O., Maini, R. N., & Feldmann, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5687 · Cited by 164
Ambarus, C. A., Noordenbos, T., de Hair, M. J., Tak, P. P., & Baeten, D. L. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3796 · Cited by 158
Parker, J. M., Oh, C. K., LaForce, C., Miller, S. D., Pearlman, D. S., Le, C., Robbie, G. J., White, W. I., White, B., & Molfino, N. A. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-14 · Cited by 156
Th2 and eosinophil responses suppress inflammatory arthritis
Zhu, C., Andreev, D., Oeser, K., Krljanac, B., Hueber, A. J., Kleyer, A., Voehringer, D., Schett, G. A., & Bözec, A. (2016) · Nature Communications · doi:10.1038/ncomms11596 · Cited by 155
Self-citationEosinophil-mediated signalling attenuates inflammatory responses in experimental colitis
Masterson, J. C., McNamee, E. N., Fillon, S., Hosford, L., Harris, R. F., Fernando, S. D., Jedlicka, P., Iwamoto, R., Jacobsen, E. A., Protheroe, C. A., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-306998 · Cited by 154
Interleukin 27 attenuates collagen-induced arthritis
Niedbała, W., Cai, B., Wei, X., Patakas, A., Leung, B. P. L., McInnes, I. B., & Liew, F. Y. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083360 · Cited by 153
van Holten, J., Reedquist, K. A., Sattonnet‐Roche, P., Smeets, T. J. M., Plater-Zyberk, C., Vervoordeldonk, M. J., & Tak, P. P. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1165 · Cited by 151
Finnegan, A., Mikecz, K., Tao, P., & Glant, T. T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5383 · Cited by 145
Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice
Yamada, T., Tani, Y., Nakanishi, H., Taguchi, R., Arita, M., & Arai, H. (2010) · The FASEB Journal · doi:10.1096/fj.10-170027 · Cited by 143
Osada, Y., Shimizu, S., Kumagai, T., Yamada, S., & Kanazawa, T. (2008) · International Journal for Parasitology · doi:10.1016/j.ijpara.2008.08.007 · Cited by 141
Matta, B. M., Reichenbach, D. K., Zhang, X., Mathews, L. R., Koehn, B. H., Dwyer, G. K., Lott, J. M., Uhl, F. M., Pfeifer, D., Feser, C. J., et al. (2016) · Blood · doi:10.1182/blood-2015-12-684142 · Cited by 132
The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells
Drube, S., Heink, S., Walter, S., Löhn, T., Grusser, M., Gerbaulet, A., Berod, L., Drube, J., Dudeck, A., Freitag, J., et al. (2010) · Blood · doi:10.1182/blood-2009-10-247411 · Cited by 129
Zaiss, M. M., Kurowska‐Stolarska, M., Böhm, C., Gary, R., Scholtysek, C., Stolarski, B., Reilly, J. H., Kerr, S. C., Millar, N. L., Kamradt, T., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003487 · Cited by 128
Self-citationHughes‐Austin, J. M., Deane, K. D., Derber, L. A., Kolfenbach, J., Zerbe, G. O., Sokolove, J. B., Lahey, L. J., Weisman, M. H., Buckner, J. H., Mikuls, T. R., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201505 · Cited by 128
IL-33 Exacerbates Autoantibody-Induced Arthritis
Xu, D., Jiang, H., Li, Y., Pushparaj, P. N., Kurowska‐Stolarska, M., Leung, B. P. L., Mu, R., Tay, H. K., McKenzie, A. N. J., McInnes, I. B., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902685 · Cited by 123
Yamada, A., Takami, M., Kawawa, T., Yasuhara, R., Zhao, B., Mochizuki, A., Miyamoto, Y., Eto, T., Yasuda, H., Nakamichi, Y., et al. (2007) · Immunology · doi:10.1111/j.1365-2567.2006.02538.x · Cited by 119
Isobe, Y., Kato, T., & Arita, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00270 · Cited by 118
IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages
Smallie, T., Ricchetti, G., Horwood, N. J., Feldmann, M., Clark, A. R., & Williams, L. M. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100414 · Cited by 115
Eosinophils Preserve Parasitic Nematode Larvae by Regulating Local Immunity
Gebreselassie, N. G., Moorhead, A. R., Fabre, V., Gagliardo, L. F., Lee, N. A., Lee, J. J., & Appleton, J. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101980 · Cited by 114
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis
Ciccia, F., Guggino, G., Rizzo, A., Manzo, A., Vitolo, B., Manna, M. P. L., Giardina, G., Sireci, G., Dieli, F., Montecucco, C., et al. (2015) · Rheumatology · doi:10.1093/rheumatology/kev252 · Cited by 113
Wong, C. K., Chen, D. P., Tam, L., Li, E. K., Yin, Y. B., & Lam, C. W. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3067 · Cited by 112
Harnett, M. M., Kean, D. E., Boitelle, A., McGUINESS, S., Thalhamer, T., Steiger, C. N., Egan, C., Al‐Riyami, L., Alcocer, M. J. C., Houston, K. M., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.073502 · Cited by 111
Pineda, M. A., McGrath, M., Smith, P. C., Al‐Riyami, L., Rzepecka, J., Gracie, J. A., Harnett, W., & Harnett, M. M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34581 · Cited by 111
Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis
Jones, G. W., Bombardieri, M., Greenhill, C., McLeod, L., Nerviani, A., Rocher-Ros, V., Figueras, A. C., Williams, A. S., Pitzalis, C., Jenkins, B. J., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20132307 · Cited by 106
Finlay, C. M., Stefanska, A. M., Walsh, K. P., Kelly, P. J., Boon, L., Lavelle, E. C., Walsh, P. T., & Mills, K. H. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501820 · Cited by 105
Isomäki, P., Luukkainen, R., Toivanen, P., & Punnonen, J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391012 · Cited by 104
van Holten, J., Pavelká, K., Vencovský, J., Stahl, H., Rozman, B., Genovese, M. C., Kivitz, A. J., Alvaro, J., Nuki, G., Furst, D. E., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.020347 · Cited by 103
Bauer, J. H., Liu, K. D., You, Y., Lai, S. Y., & Goldsmith, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9255 · Cited by 98
Al-Riyami, L., Pineda, M. A., Rzepecka, J., Huggan, J. K., Khalaf, A. I., Suckling, C. J., Scott, F. J., Rodgers, D. T., Harnett, M. M., & Harnett, W. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401251p · Cited by 94
Atkins, M. B., Vachino, G., Tilg, H., et al. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.11.1802 · Cited by 92
Local expression of interleukin‐27 ameliorates collagen‐induced arthritis
Pickens, S. R., Chamberlain, N. D., Volin, M. V., Mandelin, A. M., Agrawal, H., Matsui, M., Yoshimoto, T., & Shahrara, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30324 · Cited by 91
Kalliolias, G. D., Zhao, B., Triantafyllopoulou, A., Park‐Min, K., & Ivashkiv, L. B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27200 · Cited by 90
Key roles for lipid mediators in the adaptive immune response
Duffney, P. F., Falsetta, M. L., Rackow, A. R., Thatcher, T. H., Phipps, R. P., & Sime, P. J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97951 · Cited by 88
Mu, R., Huang, H., Li, Y., Li, C., Ye, H., & Li, Z. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100184 · Cited by 87
Interleukin 5 Is Protective during Sepsis in an Eosinophil-Independent Manner
Linch, S. N., Danielson, E. T., Kelly, A. M., Tamakawa, R., Lee, J. J., & Gold, J. A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0134oc · Cited by 85
Rzepecka, J., Pineda, M. A., Al‐Riyami, L., Rodgers, D. T., Huggan, J. K., Lumb, F. E., Khalaf, A. I., Meakin, P. J., Corbet, M., Ashford, M. L. J., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.005 · Cited by 84
The effects of interferon beta treatment on arthritis
Tak, P. P., Hart, B. A., Kraan, M. C., Jonker, M., Smeets, T. J., & Breedveld, F. C. (1999) · British journal of rheumatology · doi:10.1093/rheumatology/38.4.362 · Cited by 84
The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells
Nakatsukasa, H., Zhang, D., Maruyama, T., Chen, H., Cui, K., Ishikawa, M., Deng, L., Zanvit, P., Tu, E., Jin, W., et al. (2015) · Nature Immunology · doi:10.1038/ni.3252 · Cited by 80
Omata, Y., Frech, M., Primbs, T., Lucas, S., Andreev, D., Scholtysek, C., Sarter, K., Kindermann, M., Yeremenko, N. G., Baeten, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.005 · Cited by 80
Self-citationKalliolias, G. D., Gordon, R. A., & Ivashkiv, L. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001290 · Cited by 78
An anti‐inflammatory role for interleukin‐11 in established murine collagen‐induced arthritis
Walmsley, BUTLER, MARINOVA‐MUTAFCHIEVA, & Feldmann, M. (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00568.x · Cited by 77
Song, X., Shen, J.-L., Wen, H., Zhong, Z., Luo, Q., Chu, D., Qi, Y., Xu, Y., & Wei, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023453 · Cited by 76
Fujii, T., Kitaura, H., Kimura, K., Hakami, Z. W., & Takano‐Yamamoto, T. (2012) · Bone · doi:10.1016/j.bone.2012.06.024 · Cited by 76
Mern, D. S., Hoppe‐Seyler, K., Hoppe‐Seyler, F., Hasskarl, J., & Burwinkel, B. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0810-6 · Cited by 76
Chowdhury, K., Kumar, U., Das, S., Chaudhuri, J., Kumar, P., Kanjilal, M., Ghosh, P., Sircar, G., Basyal, R. K., Kanga, U., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1505-8 · Cited by 74
IL-9, a local growth factor for synovial T cells in inflammatory arthritis
Kundu‐Raychaudhuri, S., Abria, C. J., & Raychaudhuri, S. P. (2016) · Cytokine · doi:10.1016/j.cyto.2015.12.020 · Cited by 73
Bessis, N., Chiocchia, G., Kollias, G. A., Minty, A. J., Fournier, C., FRADELIZI, D., & Boissier, M. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00500.x · Cited by 72
Interleukin-27 and Interferon-γ Are Involved in Regulation of Autoimmune Arthritis
Rajaiah, R., Puttabyatappa, M., Polumuri, S. K., & Moudgil, K. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187013 · Cited by 68
Hart, P. H., Ahern, M. J., Smith, M., & Finlay‐Jones, J. J. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05554.x · Cited by 67
Biton, J., Athari, S. K., Thiolat, A., Santinon, F., Lemeiter, D., Hervé, R., Delavallée, L., Levescot, A., Roga, S., Decker, P., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502124 · Cited by 66
Tanida, S., Yoshitomi, H., Ishikawa, M., Kasahara, T., Murata, K., Shibuya, H., Ito, H., & Nakamura, T. (2011) · Cytokine · doi:10.1016/j.cyto.2011.04.020 · Cited by 65
Figueiredo, C. P., Bang, H., Cobra, J. F., Englbrecht, M., Hueber, A. J., Haschka, J., Manger, B., Kleyer, A., Reiser, M., Finzel, S., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209297 · Cited by 65
Self-citationShi, M., Wang, A., Prescott, D., Waterhouse, C. C. M., Zhang, S., McDougall, J. J., Sharkey, K. A., & McKay, D. M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30098 · Cited by 60
Pineda, M. A., Rodgers, D. T., Al‐Riyami, L., Harnett, W., & Harnett, M. M. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38392 · Cited by 59
Lund, M. E., Greer, J. M., Dixit, A., Alvarado, R., Winter, P. M., To, J., Tanaka, A., Hutchinson, A. T., Robinson, M. W., Simpson, A. M., et al. (2016) · Scientific Reports · doi:10.1038/srep37789 · Cited by 57
Rodgers, D. T., Pineda, M. A., McGrath, M., Al‐Riyami, L., Harnett, W., & Harnett, M. M. (2013) · Immunology · doi:10.1111/imm.12208 · Cited by 53
Regulation of group 2 innate lymphoid cells
Duerr, C. U., & Fritz, J. H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.018 · Cited by 49
Moreland, L. W., Gugliotti, R., King, K., Chase, W. F., Weisman, M. H., Greco, T., Fife, R. S., Korn, J. H., Simms, R. W., Tesser, J., et al. (2001) · Arthritis Research & Therapy · doi:10.1186/ar309 · Cited by 48
Salinas-Carmona, M. C., de la Cruz-Galicia, G., Pérez-Rivera, I., Solís-Soto, J. M., Segoviano-Ramírez, J. C., Vázquez, A. V., & Garza, M. A. (2008) · Autoimmunity · doi:10.1080/08916930802228290 · Cited by 48
Nitric oxide compounds have different effects profiles on human articular chondrocyte metabolism
de Andrés, M. C., Maneiro, E., Martín, M. A., Arenas, J., & Blanco, F. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4295 · Cited by 45
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency
Martin, P., Talabot‐Ayer, D., Seemayer, C. A., Vigne, S., Lamacchia, C., Rodriguez, E., Finckh, A., Smith, D. E., Gabay, C., & Palmer, G. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4143 · Cited by 43
An immune cell-selective interleukin 4 agonist
Shanafelt, A. B., Forte, C. P., Kasper, J. J., Sanchez-Pescador, L., Wetzel, M., Gundel, R. H., & Greve, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9454 · Cited by 41
Increased levels of interleukin-27 in patients with rheumatoid arthritis
Shen, H., Xia, L., Xiao, W., & Lu, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30180 · Cited by 32
Hirayama, T., Dai, S., Abbas, S., Yamanaka, Y., & Abu‐Amer, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21286 · Cited by 32
Immune-mediated experimental arthritis in IL-33 deficient mice
Talabot‐Ayer, D., Martin, P., Seemayer, C. A., Vigne, S., Lamacchia, C., Finckh, A., Saïji, E., Gabay, C., & Palmer, G. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.007 · Cited by 25
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Cited by
Cytokines: From Clinical Significance to Quantification
Liu, C., Chu, D., Kalantar‐Zadeh, K., George, J., Young, H. A., & Liu, G. (2021) · Advanced Science · doi:10.1002/advs.202004433 · Cited by 940
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
The IL-1 family of cytokines and receptors in rheumatic diseases
Dinarello, C. A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0277-8 · Cited by 366
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
Iwaszko, M., Biały, S., & Bogunia-Kubik, K. (2021) · Cells · doi:10.3390/cells10113000 · Cited by 311
Metadata
- Authors
- Chen, Z., Bozec, A., Ramming, A., & Schett, G.
- Venue
- Nature Reviews Rheumatology
- Published
- 2018-10-19
- Volume
- 15
- Issue
- 1
- Pages
- 9-17
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2896491161
- Cited by
- 719
- References
- 120
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.